ELF3 and ovarian cancer: ELF3-overexpressing OVCA429 and SKOV3ipluc cells exhibited 46% (p < 0.001) and 25% (p < 0.001) lower rates of cell proliferation, respectively, than did mock-transfected ovarian cancer cells (Figure 3A).